Pathway analysis identifies perturbation of genetic networks induced by butyrate in a bovine kidney epithelial cell line
暂无分享,去创建一个
Robert W. Li | Robert W Li | Congjun Li | T. Elsasser | Yong-Hong Wang | Cong-jun Li | Yong-hong Wang | Ted H. Elsasser
[1] M. Bugaut. Occurrence, absorption and metabolism of short chain fatty acids in the digestive tract of mammals. , 1987, Comparative biochemistry and physiology. B, Comparative biochemistry.
[2] E. N. Bergman. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. , 1990, Physiological reviews.
[3] C. Paraskeva,et al. The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[4] W. Scheppach,et al. Role of short-chain fatty acids in the prevention of colorectal cancer. , 1995, European journal of cancer.
[5] G. Evan,et al. A License to Kill , 1996, Cell.
[6] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] B. Dubray,et al. Histopathological and cellular studies of a case of cutaneous radiation syndrome after accidental chronic exposure to a cesium source. , 1999, Radiation research.
[8] M. Sussman,et al. Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array , 1999, Nature Biotechnology.
[9] G. Calaf,et al. Short-chain fatty acids inhibit invasive human colon cancer by modulating uPA, TIMP-1, TIMP-2, mutant p53, Bcl-2, Bax, p21 and PCNA protein expression in an in vitro cell culture model. , 2001, The Journal of nutrition.
[10] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] E. Cabré,et al. Nutrition in inflammatory bowel disease , 2001, Current opinion in clinical nutrition and metabolic care.
[12] M. DePamphilis,et al. Mammalian Orc1 Protein Is Selectively Released from Chromatin and Ubiquitinated during the S-to-M Transition in the Cell Division Cycle , 2002, Molecular and Cellular Biology.
[13] I. Johnson,et al. Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[14] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[15] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[16] L. Augenlicht,et al. Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. , 2003, Molecular cancer research : MCR.
[17] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[18] Jerry M. Adams,et al. Ways of dying: multiple pathways to apoptosis. , 2003, Genes & development.
[19] M. Yin,et al. TGF-β1 Regulates Lymphocyte Homeostasis by Preventing Activation and Subsequent Apoptosis of Peripheral Lymphocytes1 , 2003, The Journal of Immunology.
[20] D. Faller,et al. Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? , 2003, Current cancer drug targets.
[21] A. Williams,et al. IGFBP-3 and apoptosis—a licence to kill? , 2001, Apoptosis.
[22] S. Korsmeyer,et al. Review Cell Death: Critical Control Points Another Line of Evidence for the Importance of Caspases in Cell Death Came From , 2022 .
[23] M. DePamphilis,et al. Role for Cdk1 (Cdc2)/Cyclin A in Preventing the Mammalian Origin Recognition Complex's Largest Subunit (Orc1) from Binding to Chromatin during Mitosis , 2004, Molecular and Cellular Biology.
[24] 千葉 哲博. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells , 2004 .
[25] John D. Storey,et al. A network-based analysis of systemic inflammation in humans , 2005, Nature.
[26] T. Elsasser,et al. Butyrate-induced apoptosis and cell cycle arrest in bovine kidney epithelial cells: involvement of caspase and proteasome pathways. , 2005, Journal of animal science.
[27] Sung-Dae Cho,et al. Ras/MAP kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate. , 2005, Cancer letters.
[28] K. Somasundaram,et al. Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate , 2005, International journal of cancer.
[29] Claes Wahlestedt,et al. Considerations when using the significance analysis of microarrays (SAM) algorithm , 2005, BMC Bioinformatics.
[30] A. Watson. An overview of apoptosis and the prevention of colorectal cancer. , 2006, Critical reviews in oncology/hematology.
[31] Robert W. Li,et al. Butyrate induces profound changes in gene expression related to multiple signal pathways in bovine kidney epithelial cells , 2006, BMC Genomics.
[32] E. Ho,et al. Dietary agents as histone deacetylase inhibitors , 2006, Molecular carcinogenesis.
[33] Robert W. Li,et al. Identification of estrogen-responsive genes in the parenchyma and fat pad of the bovine mammary gland by microarray analysis. , 2006, Physiological genomics.
[34] Qi-Fu Li,et al. Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823. , 2006, World journal of gastroenterology.
[35] Y. Tabuchi,et al. Genetic networks responsive to sodium butyrate in colonic epithelial cells , 2006, FEBS letters.
[36] E. Ho,et al. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? , 2006, Carcinogenesis.
[37] Lakshmanan K. Iyer,et al. A combined approach to data mining of textual and structured data to identify cancer-related targets , 2006, BMC Bioinformatics.
[38] D. Spandidos,et al. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. , 2006, International journal of oncology.
[39] K. Tsuneyama,et al. High-density oligonucleotide microarrays and functional network analysis reveal extended lung carcinogenesis pathway maps and multiple interacting genes in NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] induced CD1 mouse lung tumor , 2006, Journal of Cancer Research and Clinical Oncology.
[40] R. Dashwood,et al. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. , 2006, Current drug targets.
[41] Anatoly L. Mayburd,et al. Ingenuity Network-Assisted Transcription Profiling: Identification of a New Pharmacologic Mechanism for MK886 , 2006, Clinical Cancer Research.
[42] C. Paraskeva,et al. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-κB , 2007, Cell Death and Differentiation.
[43] R. Lloyd,et al. Regulation of cell growth and expression of 7B2, PC2, and PC1/3 by TGFβ 1 and sodium butyrate in a human pituitary cell line (HP75) , 2003, Endocrine.
[44] J. Affourtit,et al. Selective degradation of transcripts during meiotic maturation of mouse oocytes. , 2007, Developmental biology.
[45] C. Paraskeva,et al. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. , 2007, Cell death and differentiation.